Soligenix (SNGX) Shareholders OK 2025 Equity Plan, Re-Elect Board

Q: How did shareholders vote on the Soligenix 2025 Equity Incentive Plan?

215,332 votes For, 91,937 Against, 57,226 Abstain, with 1,168,832 broker non-votes.

Q: Did Soligenix (SNGX) shareholders approve executive compensation?

Yes. The non-binding say-on-pay proposal passed with 303,633 For, 53,830 Against and 7,032 Abstain votes.

Q: Which audit firm will serve Soligenix for fiscal 2025?

Shareholders ratified Cherry Bekaert, LLP with 1,476,465 votes For.

[Form 4] Freshworks Inc. Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

On June 20, 2025, Soligenix, Inc. (Nasdaq: SNGX) filed an 8-K summarizing the results of its 2025 Annual Meeting of Stockholders.

2025 Equity Incentive Plan: Approved with 215,332 votes For, 91,937 Against and 57,226 Abstain (1,168,832 broker non-votes). Forms of stock option and restricted stock agreements were filed as Exhibits 10.2 and 10.3.
Board Elections: All five incumbent directors were re-elected. Support ranged from 329,054 to 332,492 votes For; broker non-votes totaled 1,168,832.
Say-on-Pay: Executive compensation received advisory approval (303,633 For; 53,830 Against; 7,032 Abstain).
Auditor Ratification: Cherry Bekaert, LLP was ratified for FY 2025 (1,476,465 For; 54,474 Against; 2,388 Abstain).
Adjournment Authority: Approved with 1,227,450 For; 295,013 Against; 10,864 Abstain.

No operational updates, financial results or major strategic transactions were disclosed; the filing is primarily governance-oriented and does not materially affect near-term fundamentals.

Positive

Continuity in leadership and oversight: All incumbent directors were re-elected and Cherry Bekaert, LLP was ratified as auditor, preserving governance stability.

Negative

Potential shareholder dilution: Approval of the 2025 Equity Incentive Plan increases the authorized share pool for equity awards.

Insights

TL;DR: Routine AGM approvals; neutral impact, minor dilution risk from new equity plan.

The 8-K covers standard governance items. Re-election of directors and auditor ratification sustain leadership continuity and reporting stability鈥攂aseline expectations for investors. The newly approved 2025 Equity Incentive Plan refreshes the share-based compensation pool, aligning management incentives but creating potential future dilution; roughly 30% of votes (Against + Abstain + broker non-votes) did not support it, signaling modest shareholder concern. With no financial metrics or strategic shifts announced, the disclosure is unlikely to drive immediate valuation changes. Overall impact is neutral.

07/03/2025 - 02:20 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NELSON ZACHARY

(Last)

(First)

(Middle)

C/O FRESHWORKS INC.

2950 S DELAWARE STREET, SUITE 201

(Street)

SAN MATEO

94403

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Freshworks Inc. [ FRSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	07/01/2025		A		13,980⁽¹⁾⁽²⁾	A	$0	38,870	D
Class A Common Stock	07/02/2025		C		8,433	A	$0	47,303	D
Class A Common Stock	07/02/2025		S⁽³⁾		8,433	D	$14.8⁽⁴⁾	38,870	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽⁵⁾	07/01/2025		M			9,370	⁽⁶⁾	08/08/2031	Class B Common Stock	9,370	$0	18,750	D
Class B Common Stock	⁽⁷⁾	07/01/2025		M		9,370		⁽⁷⁾	⁽⁷⁾	Class A Common Stock	9,370	$0	114,887	D
Class B Common Stock	⁽⁷⁾	07/02/2025		C			8,433	⁽⁷⁾	⁽⁷⁾	Class A Common Stock	8,433	$0	106,454	D

Explanation of Responses:

1. With respect to 744 shares, represents the grant of fully-vested restricted stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's Non-Employee Director Compensation Policy. Grant reflects director compensation for the second quarter of 2025. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our common stock over the 30 consecutive trading days immediately preceding July 1, 2025, rounded down to the nearest whole share.

2. With respect to 13,236 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy. Each of these RSUs represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The number of RSUs granted was calculated by dividing the applicable value of the equity by the average closing price of our common stock over the 30 consecutive trading days immediately preceding July 1, 2025, rounded down to the nearest whole share. The shares shall vest in full on July 1, 2026; provided, however, that in the event a director is up for re-election at the Issuer's next annual meeting of stockholders and is not elected to continue serving as a member of the board of directors at such annual meeting of stockholders, the shares shall be deemed fully vested on that annual meeting date.

3. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted February 28, 2025.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.65 to $15.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.

5. Each Restricted Stock Unit represents a contingent right to receive one share of Class B Common Stock.

6. The shares of Class B Common Stock underlying the RSU award granted under the Issuer's 2011 Stock Plan vest in equal monthly installments over 48 months following September 1, 2021, subject to the Reporting Person's continued service through each vesting date.

7. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock, and has no expiration date.

	/s/ Pamela Sergeeff, Attorney-in-Fact	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Which proposals were approved at Soligenix's 2025 Annual Meeting?

Shareholders approved the 2025 Equity Incentive Plan, re-elected all five directors, ratified Cherry Bekaert, LLP as auditor, passed the say-on-pay advisory vote and granted adjournment authority.

How did shareholders vote on the Soligenix 2025 Equity Incentive Plan?

215,332 votes For, 91,937 Against, 57,226 Abstain, with 1,168,832 broker non-votes.

Did Soligenix (SNGX) shareholders approve executive compensation?

Yes. The non-binding say-on-pay proposal passed with 303,633 For, 53,830 Against and 7,032 Abstain votes.

Which audit firm will serve Soligenix for fiscal 2025?

Shareholders ratified Cherry Bekaert, LLP with 1,476,465 votes For.

Were there any changes to Soligenix鈥檚 board composition?

No. All incumbent directors鈥攊ncluding Christopher J. Schaber and Gregg A. Lapointe鈥攚ere re-elected to serve until the 2026 AGM.

AG真人官方

[Form 4] Freshworks Inc. Insider Trading Activity

Insights

FAQ

Which proposals were approved at Soligenix's 2025 Annual Meeting?

How did shareholders vote on the Soligenix 2025 Equity Incentive Plan?

Did Soligenix (SNGX) shareholders approve executive compensation?

Which audit firm will serve Soligenix for fiscal 2025?

Were there any changes to Soligenix鈥檚 board composition?

NASDAQ:FRSH

FRSH Rankings

FRSH Latest News

FRSH Latest SEC Filings

FRSH Stock Data

AG真人官方

Trending News

[Form 4] Freshworks Inc. Insider Trading Activity

Insights

Corporate Governance Analyst neutral

FAQ

Which proposals were approved at Soligenix's 2025 Annual Meeting?

How did shareholders vote on the Soligenix 2025 Equity Incentive Plan?

Did Soligenix (SNGX) shareholders approve executive compensation?

Which audit firm will serve Soligenix for fiscal 2025?

Were there any changes to Soligenix鈥檚 board composition?

NASDAQ:FRSH

FRSH Rankings

FRSH Latest News

FRSH Latest SEC Filings

FRSH Stock Data